Review
Biochemistry & Molecular Biology
Stephen D. H. Malnick, Pavel Alin, Marina Somin, Manuela G. Neuman
Summary: Both alcohol-induced liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) involve abnormal fat accumulation in the liver, potentially caused by excessive alcohol consumption and the combination of alcohol consumption and medications. The liver pathology is similar in both conditions, progressing from simple steatosis to inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Evaluating the medical history of alcohol consumption, laboratory markers, AST/ALT ratio, and features of the metabolic syndrome can help estimate the contribution of alcohol intake and metabolic syndrome to liver steatosis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Liuying Chen, Huiqian Fan, Huikuan Chu, Fan Du, Yixiong Chen, Lilin Hu, Zhonglin Li, Weijun Wang, Xiaohua Hou, Ling Yang
Summary: This study aimed to investigate the role of HSP90 and its inhibitor 17-DMAG in cholangiocyte necroptosis during the progression of primary biliary cholangitis (PBC). The expression of HSP90 and necroptotic markers was evaluated in liver tissues from PBC patients and mice. The administration of 17-DMAG showed therapeutic effects in PBC mice by reducing proinflammatory cytokines and antibody levels. In vitro experiments demonstrated that 17-DMAG and necrostatin-1 prevented necroptosis of HIBECs. Furthermore, RIPK1 was found to interact with HSP90, and 17-DMAG accelerated the degradation of RIPK1.
JOURNAL OF CELLULAR BIOCHEMISTRY
(2022)
Article
Chemistry, Multidisciplinary
Kercia P. Cruz, Beatriz F. C. Patricio, Vinicius C. Pires, Marina F. Amorim, Alan G. S. F. Pinho, Helenita C. Quadros, Diana A. S. Dantas, Marcelo H. C. Chaves, Fabio R. Formiga, Helvecio V. A. Rocha, Patricia S. T. Veras
Summary: This study developed PLGA nanoparticles containing 17-DMAG using a double emulsion method, with P2 nanoparticles being smaller and more homogeneous than P1. The optimized formulation consisted of 2 mg 17-DMAG, 100 mg PLGA, 5% PEG 8000, 1.5 mL internal aqueous phase, 1% PVA, and 4 mL organic phase, showing promising release kinetics and cell uptake properties.
FRONTIERS IN CHEMISTRY
(2021)
Article
Oncology
Masanori Kawano, Kazuhiro Tanaka, Ichiro Itonaga, Tatsuya Iwasaki, Yuta Kubota, Hiroshi Tsumura
Summary: Heat shock protein 90 (HSP90) plays a crucial role in correcting protein misfolding and maintaining normal cellular functions, but also supports the maturation of cancer-related proteins. In this study, an HSP90 inhibitor, 17-demethoxygeldanamycin hydrochloride (17-DMAG), was used to treat osteosarcoma cells and inhibit cell proliferation by targeting MET. The findings suggest that this approach may lead to a new treatment strategy for osteosarcoma patients resistant to standard treatment.
Article
Pharmacology & Pharmacy
Yong Rao, Chan Li, Yu-Tao Hu, Yao-Hao Xu, Bing-Bing Song, Shi-Yao Guo, Zhi Jiang, Dan-Dan Zhao, Shuo-Bin Chen, Jia-Heng Tan, Shi-Liang Huang, Qing-Jiang Li, Xiao-Jun Wang, Ying-Jun Zhang, Ji-Ming Ye, Zhi-Shu Huang
Summary: This study found that activation of heat shock factor 1 (HSF1) can alleviate non-alcoholic steatohepatitis (NASH) through the HSF1/PPAR gamma coactivator-1 alpha (PGC-1 alpha)/mitochondrial pathway, and SYSU-3d can be considered as a potential candidate for NASH treatment.
BRITISH JOURNAL OF PHARMACOLOGY
(2022)
Article
Biotechnology & Applied Microbiology
Jiaming Zhang, Kai Wang, Jia Qi, Xiaodong Cao, Feng Wang
Summary: The study demonstrated that 17-DMAG could reduce hemorrhagic transformation in hyperglycemic rats after ischemic stroke, improve neurological function, and inhibit inflammatory response and metalloproteinase activity.
BIOMED RESEARCH INTERNATIONAL
(2021)
Review
Biochemistry & Molecular Biology
Yoon Mee Yang, Ye Eun Cho, Seonghwan Hwang
Summary: Alcoholic liver disease (ALD), caused by excessive alcohol consumption, results in liver damage. Studies have shown that there is a relationship between hepatic oxidative stress and inflammatory responses, which may be useful for developing therapeutic approaches for ALD.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Nutrition & Dietetics
Ludovico Abenavoli, Tiziana Larussa, Alessandro Corea, Anna Caterina Procopio, Luigi Boccuto, Marcello Dallio, Alessandro Federico, Francesco Luzza
Summary: NAFLD, characterized by a wide spectrum of liver disorders, is considered a major public health issue globally. Polyphenols, known for their anti-inflammatory and antioxidant properties, are believed to have potential benefits in preventing and treating NAFLD, though limited human clinical trials are available.
Review
Gastroenterology & Hepatology
Abraham Stijn Meijnikman, Hilde Herrema, Torsten Pascal Marcel Scheithauer, Jeffrey Kroon, Max Nieuwdorp, Albert Kornelis Groen
Summary: Cellular senescence is a state of irreversible cell cycle arrest with important physiological functions, but it is also associated with ageing and various pathological conditions. Senescent cells are characterized by short telomeres, enlarged nuclear area, and damaged DNA. The secretion of proinflammatory proteins is a key feature of senescent cells that is thought to contribute to their disease-inducing properties.
Review
Medicine, General & Internal
Elizabeth E. Powell, Vincent Wai-Sun Wong, Mary Rinella
Summary: Non-alcoholic fatty liver disease (NAFLD) is a common global health issue with significant associations with metabolic syndrome and type 2 diabetes, leading to serious complications like cirrhosis and hepatocellular carcinoma. While cardiovascular disease and extrahepatic malignancy are the main causes of death in NAFLD patients, advanced liver fibrosis is a key prognostic marker for liver-related outcomes and overall mortality.
Article
Cell Biology
Junliang Kuang, Jieyi Wang, Yitao Li, Mengci Li, Mingliang Zhao, Kun Ge, Dan Zheng, Kenneth C. P. Cheung, Boya Liao, Shouli Wang, Tianlu Chen, Yinan Zhang, Congrong Wang, Guang Ji, Peng Chen, Hongwei Zhou, Cen Xie, Aihua Zhao, Weiping Jia, Xiaojiao Zheng, Wei Jia
Summary: A new treatment for alleviating NAFLD has been discovered, which involves inhibiting intestinal FXR and upregulating hepatic CYP7B1 through a group of gut microbiota-modified bile acids. These bile acids can also increase the abundance of probiotic species and enhance lipid catabolism through the activation of PPARα signaling pathway, leading to an upregulation of hepatic FXR.
Review
Biochemistry & Molecular Biology
Carlos Jimenez-Cortegana, Alba Garcia-Galey, Malika Tami, Pilar del Pino, Isabel Carmona, Soledad Lopez, Gonzalo Alba, Victor Sanchez-Margalet
Summary: NAFLD affects a quarter of the global population and poses a significant health and economic burden across all countries. The lack of approved pharmacotherapy and well-established diagnostic strategies for this disease highlights the urgency for further research and management efforts. Studies have shown a strong relationship between the hormone leptin and the development of NAFLD, suggesting potential advancements in disease management through further investigation of its role.
Review
Cell Biology
Daryl Ramai, Antonio Facciorusso, Erika Vigandt, Bryan Schaf, Waleed Saadedeen, Aditya Chauhan, Sara di Nunzio, Aashni Shah, Luca Giacomelli, Rodolfo Sacco
Summary: NASH is a chronic and progressive form of non-alcoholic fatty liver disease with increasing global incidence, posing an epidemic and public health threat. The disease is associated with major morbidity and mortality, with patients at risk of developing hepatocellular carcinoma. Current evidence suggests a multi-hit model involving various pathways leading to progressive fibrosis and oncogenesis, highlighting the complexity of the disease.
Article
Multidisciplinary Sciences
Roberta D'Ambrosio, Irene Campi, Marco Maggioni, Riccardo Perbellini, Enza Giammona, Roberta Stucchi, Marta Borghi, Elisabetta Degasperi, Annalisa De Silvestri, Luca Persani, Laura Fugazzola, Pietro Lampertico
Summary: Hypothyroidism is common in NAFLD patients and is associated with increased NAFLD activity, but not with the severity of fibrosis and steatosis. Thyroid dysfunction may play a role in the pathogenesis of NAFLD and NASH.
Article
Multidisciplinary Sciences
Minxuan Xu, Jun Tan, Wei Dong, Benkui Zou, Xuepeng Teng, Liancai Zhu, Chenxu Ge, Xianling Dai, Qin Kuang, Shaoyu Zhong, Lili Lai, Chao Yi, Tingting Tang, Junjie Zhao, Longyan Wang, Jin Liu, Hao Wei, Yan Sun, Qiufeng Yang, Qiang Li, Deshuai Lou, Linfeng Hu, Xi Liu, Gang Kuang, Jing Luo, Mingxin Xiong, Jing Feng, Chufeng Zhang, Bochu Wang
Summary: This study reveals that Trim31 acts as an endogenous inhibitor of Rhbdf2 in mice, mitigating the development of NASH and potentially serving as a therapeutic target for treating NAFLD/NASH and associated metabolic disorders.
NATURE COMMUNICATIONS
(2022)
Article
Medicine, Research & Experimental
Michal Ganz, Terence N. Bukong, Timea Csak, Banishree Saha, Jin-Kyu Park, Aditya Ambade, Karen Kodys, Gyongyi Szabo
JOURNAL OF TRANSLATIONAL MEDICINE
(2015)
Article
Substance Abuse
Terence N. Bukong, Arvin Iracheta-Vellve, Benedek Gyongyosi, Aditya Ambade, Donna Catalano, Karen Kodys, Gyongyi Szabo
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
(2016)
Article
Gastroenterology & Hepatology
Terence N. Bukong, Arvin Iracheta-Vellve, Banishree Saha, Aditya Ambade, Abhishek Satishchandran, Benedek Gyongyosi, Patrick Lowe, Donna Catalano, Karen Kodys, Gyongyi Szabo
Article
Gastroenterology & Hepatology
Aditya Ambade, Abhishek Satishchandran, Benedek Gyongyosi, Patrick Lowe, Gyongyi Szabo
WORLD JOURNAL OF GASTROENTEROLOGY
(2016)
Article
Multidisciplinary Sciences
Aditya Ambade, Abhishek Satishchandran, Gyongyi Szabo
SCIENTIFIC REPORTS
(2016)
Article
Oncology
Aditya Ambade, Rita Mulherkar
Article
Gastroenterology & Hepatology
Pranoti Mandrekar, Aditya Ambade, Arlene Lim, Gyongyi Szabo, Donna Catalano
Article
Gastroenterology & Hepatology
Aditya Ambade, Donna Catalano, Arlene Lim, Pranoti Mandrekar
Article
Gastroenterology & Hepatology
Pranoti Mandrekar, Aditya Ambade
HEPATOLOGY INTERNATIONAL
(2014)
Article
Immunology
Hanfen Li, Aditya Ambade, Fabio Re
JOURNAL OF IMMUNOLOGY
(2009)
Article
Immunology
Sujatha Muralidharan, Aditya Ambade, Melissa A. Fulham, Janhavee Deshpande, Donna Catalano, Pranoti Mandrekar
JOURNAL OF IMMUNOLOGY
(2014)
Article
Immunology
Aditya V. Ambade, Ganesh V. Joshi, Rita Mulherkar
INDIAN JOURNAL OF MEDICAL RESEARCH
(2010)